QuartrQuartr

CNO: EPS guidance rose as sales momentum, agent growth, and Medicare Supplement demand continued

Less than 1 min read

Operating EPS rose 47% YoY and FY guidance increased to $5.05–$5.15. Sales and agent growth continued, while Medicare Supplement demand and investment income supported results; management flagged elevated alternative income as unlikely to persist.

Based on CNO Financial Group, Inc. [CNO] Q3 2026 Audio Transcript — Oct. 30 2026

Disclaimer